Skip to content
Back to MDWD

MediWound Ltd.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
11
Purchases
7
Sales
4
Purchase value
$142.67K
Sale value
$82.07K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Samuel RubinsteinDirector
4
Filed Sep 2, 2026Period of report Sep 1, 20260001178913-26-004392
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 1, 2026
Ordinary Shares525$12.72$6.68K0IndirectBy spouse
PurchaseSep 1, 2026
Ordinary Shares525$12.62$6.63K525IndirectBy spouse
Filing footnotes · 3
  1. F1The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
  2. F2There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  3. F3The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Open on SEC EDGAR
Shmuel HessCOO & Chief Commercial Officer
4
Filed Aug 28, 2026Period of report Aug 26, 20260001178913-26-004299
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 27, 2026
Ordinary SharesF91,979$12.72$25.17K0Direct
SaleAug 27, 2026
Ordinary SharesF91,979$13.126$25.98K0Direct
SaleAug 26, 2026
Ordinary SharesF81,865$13.00$24.25K0Direct
Filing footnotes · 10
  1. F1The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on February 26, 2024 and vest in accordance with the following schedule: 25% of the RSUs vested upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.
  2. F10There were no transactions effected in respect of the securities reported in the rows marked with this footnote, and the holdings in such rows are being included for informational purposes only.
  3. F2The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on February 11, 2025 and vest in accordance with the following schedule: 25% of the RSUs vested upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.
  4. F3The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest in accordance with the following schedule: 25% of the RSUs vested upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.
  5. F4The options reported in this row are the remaining outstanding options from a grant of 39,000 options that were granted to the Reporting Person on December 1, 2023 and that have been vesting in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.
  6. F5The options reported in this row were granted to the Reporting Person on February 26, 2024 and vest in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.
  7. F6The options reported in this row were granted to the Reporting Person on February 11, 2025 and vest in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.
  8. F7The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.
  9. F8The Reporting Person exercised 5,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 1,865 ordinary shares to the Reporting Person. All 1,865 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.
  10. F9The Reporting Person exercised 11,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 3,958 ordinary shares to the Reporting Person. All 3,958 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.
Open on SEC EDGAR
Nachum ShamirDirector
4
Filed Jun 4, 2026Period of report Jun 3, 20260001178913-26-003106
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJun 3, 2026
Ordinary Shares175$13.975$2.45K49,990Direct
PurchaseJun 3, 2026
Ordinary Shares5,825$14.00$81.55K55,815Direct
Filing footnotes · 3
  1. F1The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
  2. F2There were no transactions affected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  3. F3The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Open on SEC EDGAR
David Morton FoxDirector
4
Filed Jun 2, 2026Period of report Jun 1, 20260001178913-26-003036
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJun 1, 2026
Ordinary Shares1,730$14.225$24.61K20,476Direct
PurchaseJun 1, 2026
Ordinary Shares10$14.23$142.3020,486Direct
PurchaseJun 1, 2026
Ordinary Shares1,797$13.995$25.15K22,283Direct
Filing footnotes · 3
  1. F1The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
  2. F2There were no transactions affected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  3. F3The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Open on SEC EDGAR
Samuel RubinsteinDirector
4
Filed Jun 1, 2026Period of report May 29, 20260001178913-26-003002
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 29, 2026
Ordinary Shares150$14.33$2.15K2,993Direct
Filing footnotes · 3
  1. F1The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
  2. F2There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  3. F3The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.